Indeed, the existence of an association between sDPP4 and NAFLD/NASH may underlie a common pathogenic basis which involves increased fat accumulation and impaired insulin signaling, with suboptimal intrahepatic lipid oxidation and enhanced fat deposition. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.